{"ticker": {"uuid": "3d6997a2-566e-41ce-afda-e63673287cad", "symbol": "RHY", "name": "Rhythm Biosciences Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Rhythm Biosciences (ASX:RHY) Shares Climb 14%: Here's What Investors Are Watching", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNcXZVS1FrWkJISVY3eUZBajZydTlVVnZ1QnJJWENTMmZzVEUxMnpPVWhQWm9xV2N3X2JkaE9JdHNrV1Q3MjFQbUxCQ3pka1A2WGt5bGNvX0xrclA1RllwSTBjSzg1dzV6UzdEbGhJWjlLdE1vOW9rWUVjYzM3ckI3aUxnMmZDZFVnQnJ3UGQ4c0ltWUVOaFFIZldzdV9VT2ZNWENfa2Nwem9tUzVhdV9JTFNzWm0?oc=5", "source_name": "Kalkine", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX:RHY): Why This ASX Biotech Stock Down Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQaDhyVUxrZ2dKbVZBUTJ6VjJYTkx3NVNQS2JoY1BQczlUZS1ZVDV6b3lMZ0pOTXNtODBYaDFyNmtRemY3QXQxQzYwaGhrUE53WlBmS1R5WXRma2M5emE0U1I5M3B5MjJfR1lqcFdqSHc2eVh6bnRWVU5nc0FZd2k3RXVxSDBTaHJQak9GaUlaMklvd1BMM0hLejRqLThIcTV6NjUtaXlnVQ?oc=5", "source_name": "Kalkine", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences\u2019 ColoSTAT has been commercialised and the roll out will ramp up fast!", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBrOUNDNGtzX2M3OXFZeFo4MnowVnQxUWtpQy1lYlplRGxXVXZDczh1U3VOWFhiTEhKVnlDcDRLSTd6NGJuMFM0NEZKeWZSZXJvSWIzbVEzdnJraExfa0V0bWZxWmxrVE9YLWxRTUd3?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX:RHY) Shares Jump as Investors Track Healthcare Sector Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPNnc0c3ZvZjA0WC1JdEo3YzhzTmNPLTZUTVZ6Y244Y1NhUVhWa0JSd2FWcmM4OXo0NWxpWW9JTkphUTFBMXBKeGl1ZmsxTjN2cktxMmx2NXZsNUZjNl9vMVh1S3JlX1JIaTQxT09Xa05oZG8tNFhZaGFBb1JmUkl4TG9uNEgyNTF1ay1MMGIyZ2dDOTVjREUxTDVCdThqREVxaS0yVUtZWTZfQ0RQUzJnMWF4RzJ6Sm90aG1MMGpVWQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX:RHY) is now cleared to offer its ColoSTAT test to patients in Australia!", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE1VMVRwcllpUklHRU8xZi03ZVhkRVNfODJIWjJidkNlV25zeU9fZHphVE1GQmdTalNQVDFSZzhhekhsdlJSQ2RHRVdKd2lBQW0xdUlyN1lvZjFyaTR3bU9wT1oyZjBsMXNFNVVIMVJEWGk?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-03-13T01:24:47+00:00", "published_display": "13 Mar 2026 01:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm inks local distribution deal for its next-gen bowel cancer assay", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBpZmFCZFA1UjNMdTNLM25pbW00NlgySHprMmZEd2YwSmNxS3dEbWdTYzJRc21sLWZVTU5PTFZvVm90MXNZZFNzWmZLY1hZQ3dpQy14OHRTaUVJZHotMVZjblBPNGJYSUVYRm13bjI1ZWhPeFdsRWhiQkgtazlqS3M?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Blood Test Instead of a Colonoscopy? Rhythm Biosciences (ASX:RHY) Takes Its First Commercial Step", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQUmxqMDdJXzg1LXN0LTFOZ3dLNHdxTUoxWUNUWGo5dXFYR3FWRjg5cmc4R3Mxdjh0Q0VCeGJ0MXlabnBLYWtFWEI3bGVkd09oZkRoUnpuOW1aNFpQbEZVT0FLZExYN1hjVEplUGdxT3EzMUpIckJyN210dXU2OExKQQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences begins ColoSTAT commercial deployment with first physician enrollment", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOX2ctNjRfdWM0ZzJzQklQeWVyOEVGRk5MdU1CT21rUy00NWxVRVI5aTFUY0pzSFVERnB0aVdONWJfVC1wUW9QbHVaRHItTk1YSUVTa0hEMWo2WUszTllMbGFXZEY3ZWx6Y3JkMUV2Z09McW9fazBXSko4aC1HSkxDXzJfTzViT2JTWVJPVXJvQ25oRm9LX1lvMTBhQkJKbV9QYVFEQ3p6STRlMU5MczR0VjdOR19faWU2aktPalBn?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The 38% return this week takes Rhythm Biosciences' (ASX:RHY) shareholders one-year gains to 167%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences Secures Key Manufacturing Deal for ColoSTAT", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPZ0c1b1ZEN2FocHdUcXU1QjdnT1VVREEzb0o1ZmNxZU5XSl9SblVzSEZZdmF5TU1DMENnYkdGcTVpWFpPb0h1d0tvSmVNQTlCMzVUWGx3bHRJQm53TjhEMUxfbDBBWngwM05OTm5mTzE4eW1DSHN0NFI0RW9jdGNUZzVQalhHMzdwWENuZjlPQm14Y082Um9KYUpTYw?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm\u2019s ColoSTAT blood test clinically validated", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long Shortz: Rhythm Biosciences", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm launches ColoSTAT in Australia", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2025-12-12T08:00:00+00:00", "published_display": "12 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Rhythm Biosciences (ASX:RHY) a Buy After Securing NHS Expertise and US Distribution Deal?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOSUJUMDdJQ2F2NEJOY3JwRUQzckxyNDdBajZBRUlza0xfSFFrRmhHcUtqSnYzWU40UkhHbk15NklQaTRWeFpZNV9hSUE3aURhSFd2dEdsdWlHeTY5MmFZR08tblk5N0R1OFdfRWdiUVB5RUJwNFRtbkNsODZBWFNwcWNydVlDS3hJNTRWZ2RjcF8yTUR4UHpHU1VYZW5RRVZLNHFWS0ZPQkFBZ3Z1d2NSaU9YTjZ1RWQyTUIydw?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-12-11T08:00:00+00:00", "published_display": "11 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX: RHY): Interview with CEO David Atkins", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE14a0x2LTN1V0FHX0RyUjBLUUZyMlNLejV1U29seTVFVDdKeGFoUFJobzF4VlFYLUx3RVlWTjVfazM4NkJCbkxZNlRsSmFCdktnU2JtYTlSOE96dnItUy1Zb3Z2Q1dIeEJBZ3A2RFpHazA1NHpabUM0?oc=5", "source_name": "Stocks Down Under", "published_at": "2024-10-04T07:00:00+00:00", "published_display": "04 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences Limited (ASX: RHY) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNX3F4QmU1emdYLWI3NHBiSVE5S1pORWRCalg4MmRta2NteVpUNE5oNWpCSi1pTWp1ZlRLbExFTjdwT19JVk5na2RqRFVOU1c4Y09PeThaR1llc3IzOEVwV3hyWE8tdmNjVktzZmZpU2Vma0tITW05Q0ptU0RmUlVtV1FkTWQ3V2doRmtQZXhYWDdERHg5OUpJ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-04T22:23:38+00:00", "published_display": "04 Feb 2020 22:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences Limited (ASX: RHY) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQU0FaRVVzY0laTHh3STVqaTduVXZJV2hobHBhSy1aczVBY3BRUXBDNlBwQzcyZDJCQm85Ry1GLWc3SXlVQ093dUNvSWEyeGlMZW1xXzhLUkxvajFIMUxWMFp5VHpwTzJ2ZVhER1hwakZqZTVnNU55R1JzRFRhRHJreTJsRXN4VUstR3pZLWpCcXdUdFgtd21tSURR?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-10-02T04:07:05+00:00", "published_display": "02 Oct 2019 04:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences Limited (ASX:RHY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPVFhoNWxSVnF4aVZacElaMmxPQ19yOHJCU2VQOEViSTVrcDcyREV6UmlORWJzdkE2czFfd3Vmd19QcXZMekxLVEFBQmtpN2tWamlIU1lNRFdrVFh3cUk4M3lKaW5ZS2RxY0RCRVppT3ppUkVZOEZIcDZObmlDLVhlVkpzbU81cHc?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-23T18:52:39+00:00", "published_display": "23 Sep 2019 18:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RHY Stock Price and Chart \u2014 ASX:RHY", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFB5QXVEMS1rcmF6cXNXSnIyTFgxakptRlZ3cjNhZ2lZVzhGblpRN3FEM0FrUkx0S3RfdFVJSUZHbm1MQnVDY2hSVkxmaFRqOXpKdXc2U0RaZw?oc=5", "source_name": "TradingView", "published_at": "2017-12-08T06:08:23+00:00", "published_display": "08 Dec 2017 06:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences aims for ASX listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNdjlqMU9uUlp1SGlzaGxVUUNVb0dpU1JBY0dDbVJEUEpqS3lFNEVraFFwczhUeDFUeWhnUE9YY2p0STJPci1rRVRPOWZVWjdnM3hMX1h2VE4yWm41Znd0RDdrNWVKQTJYRHFsTU1LOFc0a2xFVU81ekpYQVBrVG9hSTYyQmhWaUhfdTgtZmtlZ1ljTERIeTNLU0sxSkt4bUxQdXVkX0lQVDZGaXVq?oc=5", "source_name": "AFR", "published_at": "2017-12-03T08:00:00+00:00", "published_display": "03 Dec 2017 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Rhythm Biosciences (ASX:RHY) Shares Climb 14%: Here's What Investors Are Watching", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNcXZVS1FrWkJISVY3eUZBajZydTlVVnZ1QnJJWENTMmZzVEUxMnpPVWhQWm9xV2N3X2JkaE9JdHNrV1Q3MjFQbUxCQ3pka1A2WGt5bGNvX0xrclA1RllwSTBjSzg1dzV6UzdEbGhJWjlLdE1vOW9rWUVjYzM3ckI3aUxnMmZDZFVnQnJ3UGQ4c0ltWUVOaFFIZldzdV9VT2ZNWENfa2Nwem9tUzVhdV9JTFNzWm0?oc=5", "source_name": "Kalkine", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX:RHY): Why This ASX Biotech Stock Down Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQaDhyVUxrZ2dKbVZBUTJ6VjJYTkx3NVNQS2JoY1BQczlUZS1ZVDV6b3lMZ0pOTXNtODBYaDFyNmtRemY3QXQxQzYwaGhrUE53WlBmS1R5WXRma2M5emE0U1I5M3B5MjJfR1lqcFdqSHc2eVh6bnRWVU5nc0FZd2k3RXVxSDBTaHJQak9GaUlaMklvd1BMM0hLejRqLThIcTV6NjUtaXlnVQ?oc=5", "source_name": "Kalkine", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences\u2019 ColoSTAT has been commercialised and the roll out will ramp up fast!", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBrOUNDNGtzX2M3OXFZeFo4MnowVnQxUWtpQy1lYlplRGxXVXZDczh1U3VOWFhiTEhKVnlDcDRLSTd6NGJuMFM0NEZKeWZSZXJvSWIzbVEzdnJraExfa0V0bWZxWmxrVE9YLWxRTUd3?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX:RHY) Shares Jump as Investors Track Healthcare Sector Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPNnc0c3ZvZjA0WC1JdEo3YzhzTmNPLTZUTVZ6Y244Y1NhUVhWa0JSd2FWcmM4OXo0NWxpWW9JTkphUTFBMXBKeGl1ZmsxTjN2cktxMmx2NXZsNUZjNl9vMVh1S3JlX1JIaTQxT09Xa05oZG8tNFhZaGFBb1JmUkl4TG9uNEgyNTF1ay1MMGIyZ2dDOTVjREUxTDVCdThqREVxaS0yVUtZWTZfQ0RQUzJnMWF4RzJ6Sm90aG1MMGpVWQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX:RHY) is now cleared to offer its ColoSTAT test to patients in Australia!", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE1VMVRwcllpUklHRU8xZi03ZVhkRVNfODJIWjJidkNlV25zeU9fZHphVE1GQmdTalNQVDFSZzhhekhsdlJSQ2RHRVdKd2lBQW0xdUlyN1lvZjFyaTR3bU9wT1oyZjBsMXNFNVVIMVJEWGk?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-03-13T01:24:47+00:00", "published_display": "13 Mar 2026 01:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm inks local distribution deal for its next-gen bowel cancer assay", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBpZmFCZFA1UjNMdTNLM25pbW00NlgySHprMmZEd2YwSmNxS3dEbWdTYzJRc21sLWZVTU5PTFZvVm90MXNZZFNzWmZLY1hZQ3dpQy14OHRTaUVJZHotMVZjblBPNGJYSUVYRm13bjI1ZWhPeFdsRWhiQkgtazlqS3M?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Blood Test Instead of a Colonoscopy? Rhythm Biosciences (ASX:RHY) Takes Its First Commercial Step", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQUmxqMDdJXzg1LXN0LTFOZ3dLNHdxTUoxWUNUWGo5dXFYR3FWRjg5cmc4R3Mxdjh0Q0VCeGJ0MXlabnBLYWtFWEI3bGVkd09oZkRoUnpuOW1aNFpQbEZVT0FLZExYN1hjVEplUGdxT3EzMUpIckJyN210dXU2OExKQQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences begins ColoSTAT commercial deployment with first physician enrollment", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOX2ctNjRfdWM0ZzJzQklQeWVyOEVGRk5MdU1CT21rUy00NWxVRVI5aTFUY0pzSFVERnB0aVdONWJfVC1wUW9QbHVaRHItTk1YSUVTa0hEMWo2WUszTllMbGFXZEY3ZWx6Y3JkMUV2Z09McW9fazBXSko4aC1HSkxDXzJfTzViT2JTWVJPVXJvQ25oRm9LX1lvMTBhQkJKbV9QYVFEQ3p6STRlMU5MczR0VjdOR19faWU2aktPalBn?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The 38% return this week takes Rhythm Biosciences' (ASX:RHY) shareholders one-year gains to 167%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences Secures Key Manufacturing Deal for ColoSTAT", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPZ0c1b1ZEN2FocHdUcXU1QjdnT1VVREEzb0o1ZmNxZU5XSl9SblVzSEZZdmF5TU1DMENnYkdGcTVpWFpPb0h1d0tvSmVNQTlCMzVUWGx3bHRJQm53TjhEMUxfbDBBWngwM05OTm5mTzE4eW1DSHN0NFI0RW9jdGNUZzVQalhHMzdwWENuZjlPQm14Y082Um9KYUpTYw?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm\u2019s ColoSTAT blood test clinically validated", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long Shortz: Rhythm Biosciences", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm launches ColoSTAT in Australia", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2025-12-12T08:00:00+00:00", "published_display": "12 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Rhythm Biosciences (ASX:RHY) a Buy After Securing NHS Expertise and US Distribution Deal?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOSUJUMDdJQ2F2NEJOY3JwRUQzckxyNDdBajZBRUlza0xfSFFrRmhHcUtqSnYzWU40UkhHbk15NklQaTRWeFpZNV9hSUE3aURhSFd2dEdsdWlHeTY5MmFZR08tblk5N0R1OFdfRWdiUVB5RUJwNFRtbkNsODZBWFNwcWNydVlDS3hJNTRWZ2RjcF8yTUR4UHpHU1VYZW5RRVZLNHFWS0ZPQkFBZ3Z1d2NSaU9YTjZ1RWQyTUIydw?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-12-11T08:00:00+00:00", "published_display": "11 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences (ASX: RHY): Interview with CEO David Atkins", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE14a0x2LTN1V0FHX0RyUjBLUUZyMlNLejV1U29seTVFVDdKeGFoUFJobzF4VlFYLUx3RVlWTjVfazM4NkJCbkxZNlRsSmFCdktnU2JtYTlSOE96dnItUy1Zb3Z2Q1dIeEJBZ3A2RFpHazA1NHpabUM0?oc=5", "source_name": "Stocks Down Under", "published_at": "2024-10-04T07:00:00+00:00", "published_display": "04 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences Limited (ASX: RHY) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNX3F4QmU1emdYLWI3NHBiSVE5S1pORWRCalg4MmRta2NteVpUNE5oNWpCSi1pTWp1ZlRLbExFTjdwT19JVk5na2RqRFVOU1c4Y09PeThaR1llc3IzOEVwV3hyWE8tdmNjVktzZmZpU2Vma0tITW05Q0ptU0RmUlVtV1FkTWQ3V2doRmtQZXhYWDdERHg5OUpJ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-04T22:23:38+00:00", "published_display": "04 Feb 2020 22:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences Limited (ASX: RHY) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQU0FaRVVzY0laTHh3STVqaTduVXZJV2hobHBhSy1aczVBY3BRUXBDNlBwQzcyZDJCQm85Ry1GLWc3SXlVQ093dUNvSWEyeGlMZW1xXzhLUkxvajFIMUxWMFp5VHpwTzJ2ZVhER1hwakZqZTVnNU55R1JzRFRhRHJreTJsRXN4VUstR3pZLWpCcXdUdFgtd21tSURR?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-10-02T04:07:05+00:00", "published_display": "02 Oct 2019 04:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences Limited (ASX:RHY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPVFhoNWxSVnF4aVZacElaMmxPQ19yOHJCU2VQOEViSTVrcDcyREV6UmlORWJzdkE2czFfd3Vmd19QcXZMekxLVEFBQmtpN2tWamlIU1lNRFdrVFh3cUk4M3lKaW5ZS2RxY0RCRVppT3ppUkVZOEZIcDZObmlDLVhlVkpzbU81cHc?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-23T18:52:39+00:00", "published_display": "23 Sep 2019 18:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RHY Stock Price and Chart \u2014 ASX:RHY", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFB5QXVEMS1rcmF6cXNXSnIyTFgxakptRlZ3cjNhZ2lZVzhGblpRN3FEM0FrUkx0S3RfdFVJSUZHbm1MQnVDY2hSVkxmaFRqOXpKdXc2U0RaZw?oc=5", "source_name": "TradingView", "published_at": "2017-12-08T06:08:23+00:00", "published_display": "08 Dec 2017 06:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rhythm Biosciences aims for ASX listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNdjlqMU9uUlp1SGlzaGxVUUNVb0dpU1JBY0dDbVJEUEpqS3lFNEVraFFwczhUeDFUeWhnUE9YY2p0STJPci1rRVRPOWZVWjdnM3hMX1h2VE4yWm41Znd0RDdrNWVKQTJYRHFsTU1LOFc0a2xFVU81ekpYQVBrVG9hSTYyQmhWaUhfdTgtZmtlZ1ljTERIeTNLU0sxSkt4bUxQdXVkX0lQVDZGaXVq?oc=5", "source_name": "AFR", "published_at": "2017-12-03T08:00:00+00:00", "published_display": "03 Dec 2017 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 81, "total_relevant": 21, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 19, "score": 52, "total": 21, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 90, "events": [{"event": "general", "label": "Market update", "weight": 9.9, "count": 18}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.09, "latest_week": "2026-07-10", "one_week_move": -5.2, "four_week_move": -17.3, "twelve_week_move": -52.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.499798, "market_dynamics_buy_signal": false, "relative_strength": -27.404769, "fair_value_gap": -28.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.2492, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.2% over one week, -17.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stocks Down Under", "count": 6}, {"label": "The Australian", "count": 4}, {"label": "Kalkine", "count": 3}, {"label": "intelligentinvestor.com.au", "count": 3}, {"label": "smallcaps.com.au", "count": 2}, {"label": "simplywall.st", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "AFR", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 21}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 18}, {"label": "Deals and strategy", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "90/100 classification confidence."}, {"label": "Company focus", "value": "21", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.2% over one week, -17.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Rhythm Biosciences (ASX:RHY) Shares Climb 14%: Here's What Investors Are Watching"}], "updated_at": "2026-07-18T02:26:14.757940+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}